Venture Certified
| 기술평가보증기업(기금) | 2019-04-05 ~ 2021-04-04 | 20190103106 | 2019-04-05 |
| 혁신성장유형 | 2021-04-05 ~ 2024-04-04 | 20210520030027 | 2019-04-05 |
| 혁신성장유형 | 2024-04-05 ~ 2027-04-04 | 20240521030072 | 2019-04-05 |
Revenue CAGR -6.8%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 11B | 12B | 12B |
| Operating Profit | -1.7B | -3.4B | -3.2B |
| Net Profit | -2.0B | -3.9B | -2.2B |
| Total Assets | 15B | 13B | 15B |
| Total Liabilities | 14B | 11B | 11B |
| Total Equity | 1.2B | 1.6B | 3.5B |
Debt Ratio 1180.9%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -2B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+515pp YoY)
▼ 12.6%
▲ 49.3%
▲ 42.0%
▲ 139.9%
▼ 15.8%
| Name | Position | Role |
|---|---|---|
| 이구연 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "강원특별자치도 춘천시",
"ceo_name": "이구연",
"certificate": [
{
"cert_number": "20190103106",
"changes": "",
"disclosure_date": "2019-04-05",
"first_cert_date": "2019-04-05",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2019-04-05 ~ 2021-04-04"
},
{
"cert_number": "20210520030027",
"changes": "",
"disclosure_date": "2021-05-20",
"first_cert_date": "2019-04-05",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2021-04-05 ~ 2024-04-04"
},
{
"cert_number": "20240521030072",
"changes": "",
"disclosure_date": "2024-05-21",
"first_cert_date": "2019-04-05",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2024-04-05 ~ 2027-04-04"
}
],
"company_name": "㈜케이메디켐",
"corp_no": "140111-*******",
"financials": {
"2022": {
"capital_stock": 48609000,
"cost_of_sales": 167070000,
"current_assets": 505977000,
"current_liabilities": 45542000,
"gross_profit": 1076414000,
"net_income": -217426000,
"net_income_bs": -222349000,
"non_current_assets": 967870000,
"non_current_liabilities": 1076000000,
"non_operating_expenses": 17076000,
"non_operating_income": 119574000,
"operating_profit": -319924000,
"revenue": 1243484000,
"sga_expenses": 1396338000,
"total_assets": 1473847000,
"total_equity": 352305000,
"total_liabilities": 1121542000
},
"2023": {
"capital_stock": 51217000,
"cost_of_sales": 142803000,
"current_assets": 372763000,
"current_liabilities": 19970000,
"gross_profit": 1087600000,
"net_income": -387393000,
"net_income_bs": -387393000,
"non_current_assets": 887680000,
"non_current_liabilities": 1076000000,
"non_operating_expenses": 64174000,
"non_operating_income": 15596000,
"operating_profit": -338815000,
"revenue": 1230403000,
"sga_expenses": 1426415000,
"total_assets": 1260443000,
"total_equity": 164473000,
"total_liabilities": 1095970000
},
"2024": {
"capital_stock": 53093000,
"cost_of_sales": 157803000,
"current_assets": 445390000,
"current_liabilities": 16663000,
"gross_profit": 922677000,
"net_income": -198623000,
"net_income_bs": -198623000,
"non_current_assets": 1032882000,
"non_current_liabilities": 1346200000,
"non_operating_expenses": 66835000,
"non_operating_income": 35053000,
"operating_profit": -166841000,
"revenue": 1080480000,
"sga_expenses": 1089518000,
"total_assets": 1478272000,
"total_equity": 115409000,
"total_liabilities": 1362863000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "신약후보물질, 의약중간체, 화장품 원료, 화장품",
"phone": "033-255-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 80/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |